All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| LUMO / Lumos Pharma, Inc.
|
|
|
|
|
|
|
|
| US33830X1046 / Five Prime Therapeutics Inc
|
|
|
|
|
|
|
|
| VIVO / Meridian Bioscience Inc. Call
|
|
|
|
|
|
|
|
| USO / United States Oil Fund, LP - Limited Partnership Call
|
|
|
|
|
|
|
|
| GHDX / Genomic Health, Inc.
|
|
|
|
|
|
|
|
| ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| INCY / Incyte Corporation
|
|
|
|
|
|
|
|
| SSRG / Symmetry Surgical Inc.
|
|
|
|
|
|
|
|
| ATRA / Atara Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| US29266S3040 / Endologix, Inc.
|
|
|
|
|
|
|
|
| 76028H209 / Repros Therapeutics, Inc.
|
|
|
|
|
|
|
|
| MDRX / Veradigm Inc.
|
|
|
|
|
|
|
|
| IVTY / Invuity, Inc.
|
|
|
|
|
|
|
|
| CYTR / LadRx Corp
|
|
|
|
|
|
|
|
| TMBR / Timber Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| Arrowhead Research Corp
/ (042797209) |
|
|
|
|
|
|
|
| VCYT / Veracyte, Inc.
|
|
|
|
|
|
|
|
| LENSF / Presbia PLC
|
|
|
|
|
|
|
|
| OMER / Omeros Corporation
|
|
|
|
|
|
|
|
| KITE / Kite Pharma, Inc.
|
|
|
|
|
|
|
|
| US00448Q2012 / Achillion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ALPN / Alpine Immune Sciences, Inc.
|
|
|
|
|
|
|
|
| BRK.B / Berkshire Hathaway Inc.
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc. Call
|
|
|
|
|
|
|
|
| CORI / Corium International, Inc.
|
|
|
|
|
|
|
|
| CBIO / Crescent Biopharma, Inc.
|
|
|
|
|
|
|
|
| VBIV / VBI Vaccines Inc.
|
|
|
|
|
|
|
|
| BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
| BMY / Bristol-Myers Squibb Company Call
|
|
|
|
|
|
|
|
| ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| DYAX / Dyax Corp.
|
|
|
|
|
|
|
|
| GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
| OSUR / OraSure Technologies, Inc.
|
|
|
|
|
|
|
|
| DRNA / Dicerna Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| BLUE / bluebird bio, Inc.
|
|
|
|
|
|
|
|
| NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
| MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
| LPCN / Lipocine Inc.
|
|
|
|
|
|
|
|
| LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
| AGEN / Agenus Inc.
|
|
|
|
|
|
|
|
| CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|
| MASI / Masimo Corporation
|
|
|
|
|
|
|
|
